Also known as آسٹیوپوروسس مینجمنٹ
Gastroenterologist
M.B.B.S., F.C.P.S. (Gastroenterology)
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellow Endocrin
Internal Medicine Specialist
M.B.B.S, F.C.P.S (Medicine)
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
M.B.B.S, F.C.P.S. (Medicine), Fellowship in Endocrinology
Internal Medicine Specialist
M.B.B.S , F.C.P.S. (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine), MRCP(UK)
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Internal Medicine Specialist
M.B.B.S., F.C.P.S Medicine , MRCP UK, Fellowship Training in Endocrinology
Gastroenterologist
M.B.B.S., FCPS (Gastroenterology)
Gastroenterologist
MBBS, FCPS (Medicine), FCPS (Gastroenterology)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures